Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew H Porteus

Showing results (21-30 of 141) with videos related to

Pageof 15
Sort By:
The EMBO Journal|July 1, 2006
Human SMC5/6 complex promotes sister chromatid homologous recombination by recruiting the SMC1/3 cohesin complex to double-strand breaksPatrick Ryan Potts, Matthew H Porteus, Hongtao Yu
Nature Protocols|January 26, 2018
CRISPR/Cas9 genome editing in human hematopoietic stem cellsRasmus O Bak, Daniel P Dever, Matthew H Porteus
Plos Genetics|October 3, 2006
A look to future directions in gene therapy research for monogenic diseasesMatthew H Porteus, Jon P Connelly, Shondra M Pruett
Blood|April 8, 2016
Ethical and regulatory aspects of genome editingDonald B Kohn, Matthew H Porteus, Andrew M Scharenberg
Hematology/Oncology Clinics of North America|June 30, 2022
A Curative DNA Code for Hematopoietic Defects: Novel Cell Therapies for Monogenic Diseases of the Blood and Immune SystemMatthew H Porteus, Mara Pavel-Dinu, Sung-Yun Pai
Trends in Genetics : TIG|June 18, 2018
Gene Editing on Center StageRasmus O Bak, Natalia Gomez-Ospina, Matthew H Porteus
Human Gene Therapy|July 15, 2010
Creating higher titer lentivirus with caffeineBrian L Ellis, Patrick Ryan Potts, Matthew H Porteus
Molecular Therapy. Nucleic Acids|April 25, 2013
Design and Development of Artificial Zinc Finger Transcription Factors and Zinc Finger Nucleases to the hTERT LocusKimberly A Wilson, Morgan L Chateau, Matthew H Porteus
Molecular and Cellular Biology|May 2, 2003
Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaksMatthew H Porteus, Toni Cathomen, Matthew D Weitzman, et al.
Trends in Biotechnology|January 18, 2015
Quantifying on- and off-target genome editingAyal Hendel, Eli J Fine, Gang Bao, et al.
Pageof 15

Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
The EMBO Journal|July 1, 2006
Human SMC5/6 complex promotes sister chromatid homologous recombination by recruiting the SMC1/3 cohesin complex to double-strand breaksPatrick Ryan Potts, Matthew H Porteus, Hongtao Yu
Nature Protocols|January 26, 2018
CRISPR/Cas9 genome editing in human hematopoietic stem cellsRasmus O Bak, Daniel P Dever, Matthew H Porteus
Plos Genetics|October 3, 2006
A look to future directions in gene therapy research for monogenic diseasesMatthew H Porteus, Jon P Connelly, Shondra M Pruett
Blood|April 8, 2016
Ethical and regulatory aspects of genome editingDonald B Kohn, Matthew H Porteus, Andrew M Scharenberg
Hematology/Oncology Clinics of North America|June 30, 2022
A Curative DNA Code for Hematopoietic Defects: Novel Cell Therapies for Monogenic Diseases of the Blood and Immune SystemMatthew H Porteus, Mara Pavel-Dinu, Sung-Yun Pai
Trends in Genetics : TIG|June 18, 2018
Gene Editing on Center StageRasmus O Bak, Natalia Gomez-Ospina, Matthew H Porteus
Human Gene Therapy|July 15, 2010
Creating higher titer lentivirus with caffeineBrian L Ellis, Patrick Ryan Potts, Matthew H Porteus
Molecular Therapy. Nucleic Acids|April 25, 2013
Design and Development of Artificial Zinc Finger Transcription Factors and Zinc Finger Nucleases to the hTERT LocusKimberly A Wilson, Morgan L Chateau, Matthew H Porteus
Molecular and Cellular Biology|May 2, 2003
Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaksMatthew H Porteus, Toni Cathomen, Matthew D Weitzman, et al.
Trends in Biotechnology|January 18, 2015
Quantifying on- and off-target genome editingAyal Hendel, Eli J Fine, Gang Bao, et al.
Pageof 15